# Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

> **NCT07146295** · NA · RECRUITING · sponsor: **Isabelle Henskens** · enrollment: 1760 (estimated)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node Biopsy (SLNB)
- Sentinel Lymph Node Detection
- Sentinel Lymph Node
- Lymphatic Metastasis
- Fluorescence Imaging
- Indocyanine Green (ICG)
- Radioisotopes
- Lymph Node Mapping

## Interventions

- **DRUG:** Technetium (99mTc)
- **DRUG:** Indocyanine Green
- **PROCEDURE:** Sentinel lymph node biopsy

## Key facts

- **NCT ID:** NCT07146295
- **Lead sponsor:** Isabelle Henskens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-18
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 1760 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07146295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07146295, "Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07146295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*